Summit Able To Promote Apex Plus For LASIK At Ophthalmology Conference
This article was originally published in The Gray Sheet
Executive Summary
Summit Technology's receipt on Oct. 21 of FDA approval for its Apex Plus excimer laser for use in laser-assisted in-situ keratomileusis (LASIK) could help the firm increase its market share by 30%, the firm says. Analysts estimate the firm's stake at 20%.